We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

News

SanDisk Corp. (NASDAQ:SNDK)'s New Long-Term Margin Targets Signal Structural Shift in Memory Pricing

SanDisk Corp. (NASDAQ:SNDK) told investors this week that it expects non-GAAP gross margins to sustain at approximately 80%, with operating margins near 75%, from fiscal 2028 through fiscal 2030, under a new financial model built around long-term supply agreements. The company, which focuses on …

Nitish Kishor | 14 August 2026

T Rowe Price Expects Years-Long Effort to Reverse Client Outflows

T Rowe Price, the $1.9 trillion asset management firm, reported net outflows of $6.5 billion for the quarter ending June 30, marking its 21st consecutive quarter of redemptions, though the figure represented a moderation from the two prior quarters. Chief executive Rob Sharps said …

Nitish Kishor | 14 August 2026

Supernus Pharmaceuticals CSO Reports PSU Vesting and Share Withholding

Padmanabh P. Bhatt, Senior Vice President of IP and Chief Scientific Officer of Supernus Pharmaceuticals, Inc., filed a Form 4 on August 14, 2026, disclosing transactions in common stock on August 12, 2026, related to the vesting of Performance Share Units.

Aditi Sarkar | 14 August 2026

Supernus Pharmaceuticals CMO Reports PSU Vesting and Share Withholding

Jonathan Rubin, SVP and Chief Medical Officer of Supernus Pharmaceuticals, Inc., filed a Form 4 on August 14, 2026, disclosing transactions in common stock dated August 12, 2026, related to the vesting of Performance Share Units.

Shwetambri Chauhan | 14 August 2026

Supernus Pharmaceuticals CEO Vests Performance Share Units

Jack A. Khattar, President and CEO of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), filed a Form 4 on August 14, 2026, reporting the vesting of Performance Share Units and a related tax withholding transaction dated August 12, 2026.

Aditi Sarkar | 14 August 2026

Rhythm Pharmaceuticals EVP Sells Shares After Option Exercise

Yann Mazabraud, EVP and Head of International at Rhythm Pharmaceuticals, Inc., filed a Form 4 on August 14, 2026, disclosing a stock option exercise and the sale of common shares on August 12, 2026, all executed under a pre-established Rule 10b5-1 trading plan.

Anjali Anand | 14 August 2026

Rhythm Pharmaceuticals EVP Exercises Options and Sells Shares

Jennifer Kayden Lee, Executive Vice President and Head of North America at Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), filed a Form 4 on August 14, 2026, reporting stock option exercises and a same-day sale of common stock executed on August 13, 2026.

Anjali Anand | 14 August 2026

CoreWeave COO Sachin Jain Sells 1 Share of Class A Stock

CoreWeave, Inc. Chief Operating Officer Sachin Jain filed a Form 4 on August 14, 2026, disclosing a sale of Class A Common Stock on August 12, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Nitish Kishor | 14 August 2026

H&R Block CLO Receives 17,271 Shares via PSU Vesting

Dara S. Redler, Chief Legal and Administrative Officer of H&R Block Inc, filed a Form 4 on August 14, 2026, reporting the acquisition of 17,271 shares of common stock on August 12, 2026, through the vesting of performance share units.

Vinay Lochav | 14 August 2026

Corteva Files Vylor Seed Business Separation Amendment

Corteva, Inc. filed a current report on August 14, 2026, disclosing that its subsidiary Vylor, Inc. submitted the first amendment to a Form 10 registration statement with the U.S. Securities and Exchange Commission in connection with Corteva's previously announced plan to separate its seed …

Anjali Anand | 14 August 2026
Support

Hi! How can we help you today?

Loading…